CCR9 and breast cancer: The highest number of SBs (138) was predicted in colon cancers from the 6 cancer-specific proteins, covering all the evaluated HLA alleles; the lowest number [27] was predicted in breast cancer from the single CCR9 cancer-specific protein (Fig. 1A).